“Oppenheimer: 3 Stocks That Could Surge Over 100% From Current Levels”
September 16, 2020
“MediWound Ltd. (MDWD)…
To this end, DeGeeter rates MDWD an Outperform along with a $7 price target. Should his thesis play out, a potential twelve-month gain of 117% could be in the cards…
UroGen Pharma (URGN)…
To this end, Gershell stands with the bulls, reiterating an Outperform rating. At $48, his price target brings the upside potential to 123%…
Ayala Pharmaceuticals Inc. (AYLA)…
Looking at the consensus breakdown, 2 Buys and 1 Hold have been published in the last three months. Therefore, AYLA gets a Moderate Buy consensus rating. Based on the $19.83 average price target, shares could climb 92% higher in the next year…”
https://finance.yahoo.com/news/oppenheimer-3-stocks-could-surge-161454271.html